Table 1.
Evaluation of anti-tumor effects of plant-derived foods/nutraceuticals in rat mammary carcinoma model
| Tumor frequency | Tumor incidence (%) | Tumor latency (days) | References | |
|---|---|---|---|---|
| Chlorella pyrenoidosa | ||||
| CONT | 2.88 | 79.20 | 70.74 | [13] |
| CHLO 0.3 | 2.00 | 80.00 | 74.90 | |
| CHLO 3 | 1.12a | 68.00 | 83.18a | |
| Hordeum vulgare, L. phylloma | ||||
| CONT | 3.12 | 80.00 | 87.50 | [14] |
| BAR 0.3 | 1.96 | 72.00 | 88.28 | |
| BAR 3 | 2.72 | 80.00 | 77.70 | |
| Flavin7® | ||||
| CONT | 3.40 | 100.00 | 66.64 | [15] |
| FLA 0.3 | 2.44 | 92.00 | 70.91 | |
| FLA 3 | 1.44b | 76.00c | 74.42 | |
| Origanum vulgare L., haulm | ||||
| CONT | 2.96 | 72.00 | 65.33 | [16] |
| ORE 0.3 | 1.32a | 40.00d | 75.60 | |
| ORE 3 | 2.36 | 72.00 | 77.78d | |
| Syzygium aromaticum L., glove buds | ||||
| CONT | 4.20 | 84.00 | 69.33 | [17] |
| CLO 0.1 | 2.20c | 80.00 | 75.25 | |
| CLO 1 | 1.75e | 87.50 | 76.67 | |
Footnote: CONT control group, CHLO chlorella group, BAR young barley group, FLA flavin group (fruit peel polyphenol extract), ORE oregano group, and CLO clove buds group. Foods/nutraceuticals were administered dietary in a concentrations of 0.3 and 3 % (3, resp. 30 g/kg of the diet), with exception of cloves with dosing of 0.1 and 1 %
Significantly different, ap < 0.02, bp <0 .001, cp < 0.05, dp < 0.03, ep < 0.01 vs CONT